china glp-1 World's first once-weekly combo therapy debuts in — ahead of Europe and the US China GLP-1 drug study suggests

Decreased appetite goes beyond normal satiety

The psychosocial risk factors associated with large reductions in weight and weight regain overlap significantly with those linked to perimenopause

Daily Harvest demonstrates how brands can respond to the GLP-1 shift without developing entirely new SKUs, instead repositioning existing products to meet emerging dietary needs

Most competitors raise the rate when patients move to higher doses, or run a discounted first-month price that more than doubles in month two

PMID: 21525464.

Just keep in mind that these discounts are based on inflated regular prices, so the savings may not be as dramatic as they look